Curexa Health Private Limited was incorporated on 10th June, 2015 as a wholly owned subsidiary of Highnoon Laboratories Ltd, one of Pakistan’s premier pharmaceutical companies. Right from its inception, Highnoon has cultivated a culture of quality and operational excellence. These very same principles became the foundation on which Curexa Health was established.
Curexa specializes in the area of antibiotics, primarily cephalosporins. Our dedicated, state of the art, cGMP manufacturing concern is second to none and encompasses the production of sterile powder for injections, powder for oral suspensions and capsules for the local and export markets. The broad spectrum nature of cephalosporins allows Curexa to be present across diverse therapeutic and disease segments ranging from but not limited to respiratory, gastroentology, urology, gynecology and pediatrics.
We at Curexa believe that our greatest strength is our people and our greatest asset is our continual commitment to quality. Our objectives are constantly aligned with the needs of patients, healthcare agencies and the medical community at large.